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Abstract
Etoposide (VP-16) is widely used for the treatment of several forms of cancer. The cytotoxicity of VP-16 has been assigned to the
induction of apoptotic cell death but the signaling pathway for VP-16-induced apoptosis is essentially unknown. There is some
evidence that this process depends on events associated with the loss of mitochondrial membrane potential () and/or release of
apoptogenic factors, putatively as a consequence of mitochondrial permeability transition (MPT) induction. This work evaluates
the interference of VP-16 with MPT in vitro, which is characterized by the Ca2+-dependent depolarization of , the release of
matrix Ca2+ and by extensive swelling of mitochondria.  depolarization and Ca2+ release were measured with ion-selective
electrodes, and mitochondrial swelling was monitored spectrophotometrically. Incubation of rat liver mitochondria with VP-16
results in a concentration-dependent induction of MPT, evidenced by an increased sensitivity to Ca2+-induced swelling, depolar-
ization of , Ca2+ release by mitochondria and stimulation of state 4 oxygen consumption. All of these effects are prevented by
preincubating the mitochondria with cyclosporine A, a potent and specific inhibitor of the MPT. Therefore, VP-16 increases the
sensitivity of isolated mitochondria to the Ca2+-dependent induction of the MPT. Together, these data provide a possible
mechanistic explanation for the previously reported effects of VP-16 on apoptosis induction.# 2001 Elsevier Science Ltd. All rights
reserved.
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1. Introduction
Etoposide (VP-16) is an antitumor drug used as a
single agent or in association with other chemothera-
peutic drugs against a variety of hematopoietic and
solid tumors (O’Dwyer et al., 1985). The inhibition of
topoisomerase II, induction of protein-cross-linked
DNA strand breaks, sister chromatid exchanges (Chat-
terjee et al., 1990) and formation of free radicals
(Kalyanaraman et al., 1989; Kagan et al., 1994) have
been implicated in its cytotoxicity, but the exact
mechanism of VP-16-induced cell death has not yet been
clearly defined.
The cytotoxicity of VP-16 has been suggested to be
mediated by apoptosis (Lindsay and Wallace, 1999;
Ferrano et al., 2000). Several studies with different cell
types attempting to identify apoptotic mechanisms of
VP-16 indicate early events occurring in mitochondria,
for example, release of mitochondrial cytochrome c
(Chen et al., 2000), formation of ultracondensed mito-
chondria, development of outer membrane dis-
continuities, reduction of mitochondrial membrane
potential () (Zhuang et al., 1998) and release of
intermembrane apoptogenic proteins, triggering a cas-
pase-dependent cascade (Meng et al., 2000). The role of
mitochondria is putatively related with the release of
cytochrome c and/or other apoptogenic factors that
initiate or amplify the apoptotic cascade (Chen et al.,
2000; Perkins et al., 2000). However, the mechanism
responsible for these VP-16-induced mitochondrial
events is essentially unknown.
The mitochondrial permeability transition (MPT),
characterized by mitochondrial swelling, depolarization
of , Ca2+ release and stimulation of state 4 oxygen
consumption, has been implicated in the toxicity
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mechanisms of tissue injury and cell death caused by a
number of compounds, the majority of which are oxi-
dants (Bernardi and Petronilli, 1996; Bernardi et al.,
1998). The induction of the MPT, causing the release of
cytochrome c, depression of , extensive swelling with
subsequent release and activation of intermembrane
apoptogenic factors, is considered a critical and essential
step for triggering efficient apoptosis in some cell types
(Hirsch et al., 1998; Perkins et al., 2000). Additionally,
the oxidation state of cysteine residues in the immediate
vicinity of the voltage-sensing structures by reactive
oxygen species and other oxidants has been proposed as
a critical factor for MPT induction (Petronilli et al.,
1994). As VP-16 oxidation leads to intermediate forma-
tion of hydroxyl and phenoxyl radicals (Kalyanaraman
et al., 1989; Kagan et al., 1994), increases the peroxide
formation and glutathione depletion in cells (Siitonen et
al., 1999), it is tempting to propose that VP-16 may
induce MPT and subsequent release of the mitochon-
drial apoptogenic factors involved in the signaling path-
way of apoptosis. This study, reporting the effects of VP-
16 on Ca2+-dependent MPT in liver mitochondria,
warrants significant support to this hypothesis.
2. Materials and methods
2.1. Materials
Etoposide (VP-16), HEPES, cyclosporine (CyA) and
oligomycin were purchased from Sigma Chemical Co.
(St Louis, MO, USA). Ethylene glycol-bis(b-aminoethyl
ether)N,N,N0,N0-tetraacetic acid (EGTA), tetra-
phenylphosphonium (TPP+) and sucrose were from
Merck (Darmstadt, Germany). All the other chemicals
were of research grade.
2.2. Rat liver mitochondria
Mitochondria were isolated from the liver of fasted
male Wistar rats (200–300 g) by differential centrifuga-
tion as described previously (Custo´dio et al., 1998a).
The liver tissue was quickly homogenized in 250 mm
sucrose, 10 mm HEPES (pH 7.4), 1 mm EGTA and
0.1% bovine serum albumin. The homogenate was cen-
trifuged for 10 min at 1200 g and 4C. The mitochondria
fraction was recovered from the supernatant centrifuged
at 10 000 g for 10 min and the mitochondrial pellet was
washed twice in the homogenization medium adjusted to
pH 7.2 in the absence of EGTA and BSA.
2.3. Standard incubation procedure
Mitochondria were suspended in a standard reaction
medium containing 200 mm sucrose, 10 mm Tris–Mops
(pH 7.4), 1 mm KH2PO4 and 10 mm EGTA, supple-
mented with 2 mm rotenone and 0.5 mg oligomycin/ml.
VP-16, prepared in dimethyl sulfoxide and diluted in
standard reaction medium immediately prior to each
experiment, was added to the reaction medium after
protein addition and incubated for 5 min before starting
the reactions. The results shown represent typical
recordings from experiments with at least three different
mitochondrial preparations.
2.4. Mitochondrial swelling
Changes in mitochondrial volume were monitored by
the decrease in apparent absorbance (light scattering) at
540 nm (Custo´dio et al., 1998b). Mitochondria were
suspended at 0.5 mg protein/ml in 2 ml of standard
reaction medium supplemented with 140 nmol Ca2+/mg
protein before energization with 5 mm succinate.
2.5. Membrane potential and oxygen uptake
Mitochondria (1 mg/ml) was suspended in the reac-
tion medium and the incubations were carried out at
30C in an oxygen-electrode chamber with magnetic
stirring. Mitochondrial  and oxygen consumption
were monitored simultaneously using a TPP+ sensitive
electrode (Kamo et al., 1979; Custo´dio et al., 1998b)
and a Clark-type electrode (Yellow Springs Instrument,
Model YSI 5331) (Custo´dio et al., 1994) placed in the
same closed reaction chamber.
2.6. Measurements of Ca2+ fluxes
Mitochondrial Ca2+ fluxes were evaluated by mon-
itoring the changes in Ca2+ concentration in the reac-
tion medium using a Ca2+-sensitive electrode,
according to procedures previously described (Madeira,
1975; Custo´dio et al., 1998b). The reactions were per-
formed with 1 mg protein in 2 ml of the reaction med-
ium in an open vessel with magnetic stirring and started
with 5 mm succinate after 2 min of Ca2+ addition (200
nmol/mg protein) in the absence and presence of VP-16.
3. Results
Adding Ca2+ (140 nmol/mg protein) to rat liver
mitochondria energized with succinate (Fig. 1) causes a
minimal mitochondrial swelling (trace 2). The incuba-
tion of mitochondria with VP-16 (1 mmol/mg protein)
followed by Ca2+ addition induces a large decrease in
the absorbance (trace 4), characteristic of the MPT
activation. The induction of MPT is evidenced by incu-
bating mitochondria with CyA, a potent and specific
inhibitor of the MPT, since CyA added prior to VP-16
(trace 1) or after energization (trace 3) completely pre-
vents or stops the mitochondrial swelling. Therefore,
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VP-16 promotes the Ca2+-dependent mitochondrial
swelling as a consequence of MPT induction.
The MPT triggering by VP-16 is further evidenced by
the effects on  (Fig. 2). Adding 200 nmol Ca2+ to
mitochondria energized with succinate causes a tran-
sient depolarization of , which recovers within 2 min
(Fig. 2-1). However, mitochondria preincubated with
VP-16 fail to repolarize after Ca2+ loading and undergo
an irreversible depolarization over the ensuing 12 min
(Fig. 2-2). This extensive depolarization is completely
protected by CyA added prior to VP-16 (Fig. 2-3).
Moreover, when added to depolarized mitochondria,
CyA induces repolarization of mitochondrial 
depressed by VP-16 (Fig. 2-4). These events clearly
indicate MPT induction by VP-16, according to data of
mitochondrial swelling (Fig. 1).
Fig. 3 reports the effect of VP-16 on mitochondrial
respiration recorded simultaneously to  with both
oxygen- and TPP+-selective electrodes placed in the
same closed reaction chamber. The addition of Ca2+
(200 nmol/mg protein) to mitochondria energized with
succinate induces a transient increase in the rate of
oxygen consumption, which returns to respiratory state
4 within 2.5 min (trace 1), that is, the time required for
accumulation of added Ca2+. However, the previous
addition of VP-16 to mitochondria causes full uncou-
pling of respiration (trace 2) which parallels the irrever-
sible depolarization of membrane potential (Fig. 2). CyA
added prior to VP-16 (trace 3) or during stimulated
respiration induced by Ca2+ (trace 4) avoids the Ca2+-
induced uncoupling of mitochondrial respiration pro-
moted by VP-16.
Further evidence that VP-16 induces MPT is provided
by the release of Ca2+ accumulated by mitochondria
(Fig. 4). Mitochondria energized with succinate retain
Ca2+ taken up within about 20 min (trace 1). After
exposure to VP-16 mitochondria release the accumu-
lated Ca2+ (trace 2), but co-incubation with CyA pre-
vents this effect, affording complete capacity to
accumulate and retain the added Ca2+ (trace 3). Fur-
thermore, adding CyA during the course of the MPT
reverses the Ca2+ release (trace 4), in agreement with
the repolarization effect (Fig. 3), occurring accumula-
tion of Ca2+ as in mitochondria energized in the
absence of VP-16 (trace 1).
4. Discussion
Mitochondria have a large capacity for Ca2+ uptake
and function as an intracellular buffer by actively
sequestering Ca2+ from the cytoplasm before under-
going the Ca2+-dependent MPT (Bernardi et al., 1998).
Exposure to oxidants or a number of different chemicals
is known to increase the sensitivity of isolated mito-
chondria to the Ca2+-dependent induction of MPT
(Petronilli et al., 1994; Bernardi et al., 1998).
VP-16 increases the sensitivity of mitochondria to
Ca2+-induced swelling (Fig. 1), depolarization of 
(Fig. 2), Ca2+ release (Fig. 4) and renders the mito-
chondria highly susceptible to the uncoupling effect of
Ca2+ (Fig. 3). All these effects of VP-16 are inhibited by
CyA that also affords complete capacity of mitochon-
dria to sequester the Ca2+ released, to recover mem-
brane potential and to prevent the Ca2+-induced
uncoupling of mitochondrial respiration when added
during the time course of the reactions. As VP-16 does
not alter state 4 respiration (Fig. 3) and  (Fig. 2),
these effects clearly demonstrate that VP-16 induces the
CyA-sensitive MPT as the result of a direct effect on the
MPT megachannel complex.
VP-16-induced MPT is also prevented by ascorbate
(data not shown), the primary reductant of the phe-
noxyl radical of etoposide (Kagan et al., 1994), sug-
gesting the generation of free radicals as a potential
mechanism underlying MPT and apoptosis induction,
in agreement with other studies (Siitonen et al., 1999;
Perkins et al., 2000). Moreover, recently it has been
shown that the pro-apoptotic factors Bax and Bak
induce mitochondrial changes such as cytochrome c
release and the loss of  by direct interaction with
MPT, and overexpression of Bax promotes apoptosis
Fig. 1. Ca2+-dependent induction of the mitochondrial swelling by
etoposide (VP-16). Rat liver mitochondria (0.5 mg protein/ml) were
incubated at 30C in 2 ml of reaction medium containing 200 mm
sucrose, 10 mm Tris–Mops (pH 7.4), 1 mm KH2PO4 and 10 mm EGTA,
supplemented with 2 mm rotenone and 0.5 mg oligomycin/ml. Mito-
chondria were energized with 5 mm potassium succinate after 2 min of
Ca2+ addition (140 nmol/mg protein) in the absence (2) and presence
of VP-16 (1 mmol/mg protein) (4) preincubated for 5 min with mito-
chondria. CyA (1 mm) was added before VP-16 (1) or after mitochon-
dria energization as indicated by the arrow (3). The traces were
obtained by following continuously the light scattering at 540 nm and
are typical direct recordings from several separate experiments.
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Fig. 3. Effect of etoposide (VP-16) on mitochondrial oxygen consumption. Oxygen uptake was monitored using a Clarke-type YSI electrode
simultaneously with the recording of membrane potential. The reactions were carried out in a closed chamber under conditions identical to those
described for Fig. 2. At the points indicated by the arrows, succinate, Ca2+, VP-16 and CyA were added. The traces represent typical recordings
from three separate experiments with different mitochondrial preparations.
Fig. 2. Effect of etoposide (VP-16) on mitochondrial membrane potential (). Mitochondria were incubated at 30C in a closed reaction chamber
at 1 mg protein/ml in 200 mm sucrose, 10 mm Tris–Mops (pH 7.4), 1 mm KH2PO4 and 10 mm EGTA, supplemented with 2 mm rotenone, 0.5 mg
oligomycin/ml and 4 mm TPP+.  was recorded continuously using a TPP+ selective electrode as described in Materials and Methods. The reac-
tions were initiated by adding 5 mm succinate. Ca2+ (200 nmol/mg protein) was added after a steady-state of TPP+ signal in the absence (1) or
presence of 1 mmol VP-16/mg protein incubated with mitochondria for 5 min (2). CyA (1 mm) was preincubated with mitochondria (3) or added after
Ca2+-induced depolarization (4). All traces are representative of three independent experiments.
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on induction of MPT (Pastorino et al., 1998). Some
questions have been raised about the involvement of
mitochondrial  collapse and cytochrome c release as
markers for apoptosis, since they are cell type- and
inducer-dependent phenomena (Tang et al., 1998; Sal-
violi et al., 2000). However, several studies point out
that mitochondria play a key role in apoptotic cascade
and that the induction of MPT leads to cell death by
releasing several activators of apoptosis (Fadeel et al.,
1999; Tafani et al., 2000). Therefore, the induction of
the MPT by VP-16 can directly promote the release of
mitochondrial apoptogenic factors involved in the sig-
naling pathway for VP-16-induced apoptosis. More-
over, the irreversible (high-conductance) MPT
induction causes prolonged mitochondrial  depolar-
ization across the inner mitochondrial membrane (Petit
et al., 1998), resulting either in the loss of MPT func-
tions involved in Ca2+ signaling and in the regulation of
Ca2+ (Bernardi and Petronilli, 1996) or uncoupling of
mitochondria, stimulation of respiration, swelling and
ATPase (Petit et al., 1998; Shinohara et al., 1998). The
consequent disruption of mitochondria functions in cel-
lular Ca2+ homeostasis, uncoupling of phosphorylation
from respiration and activation of mitochondrial
ATPase, depleting cellular ATP and accounting for
accidental/toxic cell death (Ichas and Mazat, 1998),
might also contribute to the antiproliferative activity of
VP-16 observed in different cell types. In conclusion, the
induction of apoptosis and/or cellular ATP depletion as
consequence of VP-16-induced MPT might explain the
cytostatic activity of this drug and side-effects in normal
cells observed in vivo.
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